What question did this study set out to answer?

To summarize twenty-five years of research on human metapneumovirus (HMPV) and its clinical implications.

July 12, 2026

Twenty-five years of human metapneumovirus research

EMElhadji Birane MboupUniversité Claude Bernard Lyon 1 JDJulia DuboisUniversité Claude Bernard Lyon 1 MHMarie-Ève HamelinUniversité Claude Bernard Lyon 1

Puntos clave

To summarize twenty-five years of research on human metapneumovirus (HMPV) and its clinical implications.
Reviewed findings from past HMPV research spanning 25 years.
Highlighted differences between HMPV and respiratory syncytial virus (RSV).
Discussed current research areas including epidemiology and clinical trials.
Identified changing epidemiology and clinical burden of HMPV infections.
Outlined host responses and current therapeutic options in clinical trials.
Emphasized need for further research to address the impact of HMPV.

Resumen

SUMMARY The year 2026 marks the 25th anniversary of the discovery of human metapneumovirus (HMPV), which belongs to the metapneumovirus genus within the Pneumoviridae family. The respiratory syncytial virus (RSV), discovered in 1956, is a close relative of HMPV belonging to the same family but to a different genus. In this article, we review key past findings related to HMPV infection, highlighting the differences with RSV. In addition, we specifically discuss current research areas pertaining to changing epidemiology, clinical burden, host response, as well as therapeutic and prophylactic modalities now in clinical trials. Additional research on HMPV is needed to contain this important respiratory virus.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo